Biosint S.p.A. is an Italian company founded in 1979 and specializes in the manufacturing of pharmaceutical and nutraceutical raw materials. With a sprawling area of about 130,000 m2, including 18,000 m2 of covered space in the industrial zone of Sermoneta (LT), the company is a leader in the production of pharmacologically active raw materials for human and veterinary use. It is a subsidiary of Alfasigma S.p.A.
The company operates dedicated production facilities for pharmaceutical raw materials and active ingredients for nutraceutical use, with independent and autonomous manufacturing lines and departments. Recently, Biosint S.p.A. has established a new department authorized by AIFA for the industrialization of a new process allowing the production of pharmaceutical-grade Lactic Ferments as raw materials and their bulk blends.
Biosint S.p.A.’s manufacturing facilities not only perform conventional operations such as concentration, crystallization, centrifugation, drying, lyophilization, blending, and packaging but also undertake unique activities not commonly found in similar sites, including the use of different types of ion exchange resins and pilot-scale electrodialysis units.
With its strong foothold in the pharmaceutical and nutraceutical raw materials market, Biosint S.p.A. presents a promising investment opportunity for venture capitalists seeking to tap into the thriving industrial and manufacturing sectors in Italy.